Therapies aimed at the gut microbiota and inflammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies.
AuthorsQuigley, Eamonn M M
AffiliationDepartment of Medicine, Alimentary Pharmabiotic Centre, Cork University Hospital, University College Cork, Clinical Sciences Building, Cork, Ireland. firstname.lastname@example.org
Irritable Bowel Syndrome
MetadataShow full item record
CitationTherapies aimed at the gut microbiota and inflammation: antibiotics, prebiotics, probiotics, synbiotics, anti-inflammatory therapies. 2011, 40 (1):207-22 Gastroenterol. Clin. North Am.
JournalGastroenterology clinics of North America
AbstractSeveral recent observations have raised the possibility that disturbances in the gut microbiota and/or a low-grade inflammatory state may contribute to symptomatology and the etiology of irritable bowel syndrome (IBS). Consequent on these hypotheses, several therapeutic categories have found their way into the armamentarium of those who care for IBS sufferers. These agents include probiotics, prebiotics, antibiotics, and anti-inflammatory agents.
- Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome.
- Authors: König J, Brummer RJ
- Issue date: 2014 Sep
- Modulation of the gut microbiota: a focus on treatments for irritable bowel syndrome.
- Authors: Harris LA, Baffy N
- Issue date: 2017 Nov
- Gut microbiota role in irritable bowel syndrome: New therapeutic strategies.
- Authors: Distrutti E, Monaldi L, Ricci P, Fiorucci S
- Issue date: 2016 Feb 21
- Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options.
- Authors: Bonfrate L, Tack J, Grattagliano I, Cuomo R, Portincasa P
- Issue date: 2013 Sep
- Review article: probiotics and prebiotics in irritable bowel syndrome.
- Authors: Spiller R
- Issue date: 2008 Aug 15